Showing results (91-100 of 407) with videos related to
Sort By:
Pageof 41
Infectious Disease Clinics of North America|December 15, 2019
Collaborative Antimicrobial Stewardship: Working with Hospital and Health System AdministrationWhitney R Buckel, Keith S Kaye, Payal K PatelClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2018
Ceftazidime/Avibactam, Meropenem/Vaborbactam, or Both? Clinical and Formulary ConsiderationsJason M Pogue, Robert A Bonomo, Keith S KayeExpert Review of Anti-Infective Therapy|October 30, 2018
Meropenem-vaborbactam for adults with complicated urinary tract and other invasive infectionsOwen R Albin, Twisha S Patel, Keith S KayeInfection Control and Hospital Epidemiology|February 27, 2010
Hand hygiene noncompliance and the cost of hospital-acquired methicillin-resistant Staphylococcus aureus infectionKeith L Cummings, Deverick J Anderson, Keith S KayeMicrobiology (Reading, England)|June 9, 2005
Population structure of group B streptococcus from a low-incidence region for invasive neonatal diseaseNaiel Bisharat, Nicola Jones, Dror Marchaim, et al.Journal of Global Antimicrobial Resistance|January 7, 2020
The impact of improper empirical usage of antipseudomonals on admission to an acute care hospitalNirit Kronenfeld, Shani Zilberman-Itskovich, Tsillia Lazarovitch, et al.Antibiotics (Basel, Switzerland)|July 27, 2022
Empiric Usage of "Anti-Pseudomonal" Agents for Hospital-Acquired Urinary Tract InfectionsOri Rahat, Murad Shihab, Elhai Etedgi, et al.American Journal of Infection Control|December 4, 2012
Predictors and outcomes of linezolid-resistant vancomycin-resistant Enterococcus: a case-case-control studyKayoko Hayakawa, Dror Marchaim, Jason M Pogue, et al.Hospital Practice (1995)|May 10, 2015
Ceftaroline fosamil for the treatment of hospital-acquired pneumonia and ventilator-associated pneumoniaKeith S Kaye, George Udeani, Phillip Cole, et al.Infection Control and Hospital Epidemiology|May 4, 2005
The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistanceKeith S Kaye, Anthony D Harris, Matthew Samore, et al.Pageof 41